Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SFBC Anapharm
Quebec City, Quebec, Canada
- Ownership
- Private
- Development stage
- Other
01
Overview
SFBC Anapharm was a leading Contract Research Organization (CRO) that specialized in bioanalytical services and early-phase clinical trials. The entity was formed when SFBC International acquired the Quebec-based Anapharm in 2002 to expand its clinical research capabilities into the Canadian market. The company was well-regarded for its expertise in bioequivalence studies, Phase I clinical trials, and advanced mass spectrometry for drug analysis. Over time, through various mergers and rebrandings, the operations of SFBC Anapharm were absorbed into Pharmanet Development Group and eventually became part of Syneos Health.
- Modalities
- Small moleculeBiologic
- Industry
- Contract Research Organization
Beyond the preview
Go deeper on SFBC Anapharm.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SFBC Anapharm.